Recombinant Bovine Sideroflexin-4 (SFXN4)

What is Sideroflexin-4 and how does it differ from other sideroflexin family proteins?

Sideroflexin-4 (SFXN4) is an integral inner mitochondrial membrane protein that has functionally diverged from other members of the sideroflexin family. While sideroflexins 1, 2, and 3 function primarily as serine transporters, SFXN4 has evolved to assist in the assembly of respiratory chain complex I . This functional divergence is evident in gene coessentiality analysis, which shows SFXN4 clusters with complex I subunits and assembly factors, a pattern not observed with other SFXN family members . The protein contains multiple transmembrane domains characteristic of the sideroflexin family and has been identified in multiple isoforms, including one that lacks the first ~115 amino acids but retains all five predicted transmembrane domains .

What is the primary function of SFXN4 in mitochondria?

SFXN4 serves as a complex I assembly factor, specifically interacting with the MCIA (Mitochondrial Complex I Assembly) complex and assisting in the assembly of the ND2 module of complex I . Research demonstrates that SFXN4 interacts with newly synthesized ND6, one of the last subunits to be added to this module . This assembly function is critical for mitochondrial respiration, as complex I (NADH:ubiquinone oxidoreductase) is the first and largest enzyme of the mitochondrial respiratory chain responsible for electron transfer and proton pumping across the inner mitochondrial membrane . Additionally, SFXN4 may play a role in iron-sulfur (Fe-S) cluster biogenesis, though its mechanism appears distinct from its complex I assembly function .

How can researchers detect and localize SFXN4 in cellular models?

Multiple complementary techniques can be employed to detect SFXN4 expression and localization:

• Western blotting: Using specific anti-SFXN4 antibodies for protein expression levels

• Immunofluorescence microscopy: Co-staining with mitochondrial markers to confirm mitochondrial localization

• Subcellular fractionation: Followed by Western blotting to verify presence in mitochondrial fractions

• Blue-Native PAGE: For visualization of SFXN4-containing complexes

• Immunoprecipitation: Followed by mass spectrometry to identify binding partners

When designing expression vectors for recombinant SFXN4, C-terminal tags appear to preserve function, as FLAG-tagged SFXN4 successfully rescues complex I defects in SFXN4 knockout cells .

How does SFXN4 contribute to complex I assembly?

SFXN4 plays a specific role in the assembly of the ND2 module of complex I through extensive interactions with the MCIA (Mitochondrial Complex I Assembly) complex. Affinity enrichment mass spectrometry experiments have identified that the three most enriched proteins in SFXN4 pull-down experiments are ECSIT, ACAD9, and NDUFAF1, which are established assembly factors for complex I . These proteins showed a high degree of coessentiality with SFXN4 in gene essentiality dataset analysis, providing strong evidence for functionally relevant interactions .

Blue-Native PAGE analysis reveals that SFXN4 is present in high-molecular-weight complexes that co-migrate with MCIA complex components, representing different assembly intermediates of complex I . The arrangement of these MCIA-containing complex I assembly intermediates is dramatically altered in SFXN4 knockout cells, particularly affecting the Q/PP assembly intermediates .

Table 1: Key Protein Interactions of SFXN4 in Complex I Assembly

What are the consequences of SFXN4 deficiency on mitochondrial function?

SFXN4 deficiency has profound effects on mitochondrial respiration and energy production. Research demonstrates that SFXN4 knockout cells exhibit:

• Approximately 70% reduction in complex I enzymatic activity

• Significant reduction in complex I-containing supercomplexes and holoenzymes

• Impaired ATP production when provided with complex I substrates (glutamate + malate, pyruvate + malate)

• Reduced basal and maximal oxygen consumption rates

• Loss of glycolytic reserve, suggesting metabolic adaptation to rely on glycolysis for ATP production

Importantly, this represents an isolated complex I defect, as the activities of complexes II, III, and IV remain largely unaffected . This specific impact on complex I-dependent respiration while sparing other complexes confirms that SFXN4's primary role is in complex I assembly rather than having a broader role in mitochondrial function.

Table 2: Impact of SFXN4 Knockout on Mitochondrial Respiratory Chain Complexes

How is SFXN4 involved in iron-sulfur (Fe-S) cluster biogenesis?

Interestingly, while complex I (which contains multiple Fe-S clusters) is severely affected by SFXN4 deletion, other Fe-S-containing proteins and complexes (including complexes II and III) remain largely unaffected . This selective impact suggests that SFXN4's role in Fe-S biogenesis might be specific to certain Fe-S clusters or proteins, particularly those involved in complex I assembly.

What methodologies can be used to investigate SFXN4's role in Fe-S cluster biogenesis?

To investigate SFXN4's role in Fe-S cluster biogenesis, researchers can employ several complementary approaches:

• Enzyme activity assays: Measure the activity of Fe-S dependent enzymes (e.g., aconitase, complex I) in SFXN4-depleted vs. control cells

• Iron homeostasis measurements: Quantify labile iron pool levels using fluorescent probes or ICP-MS to detect iron accumulation following SFXN4 depletion

• 55Fe incorporation assays: Track the incorporation of radioactive iron into Fe-S proteins to assess de novo Fe-S cluster assembly

• Protein interaction studies: Identify interactions between SFXN4 and known Fe-S cluster assembly components

• Rescue experiments: Test whether supplementation with Fe-S cluster precursors or expression of other Fe-S assembly factors can rescue phenotypes in SFXN4-deficient cells

When designing these experiments, researchers should consider that SFXN4's role may be specific to certain Fe-S proteins rather than affecting all Fe-S cluster biogenesis pathways .

What diseases are associated with SFXN4 mutations or dysfunction?

SFXN4 dysfunction is associated with two main disease contexts:

• Mitochondrial disease: Mutations in SFXN4 cause mitochondrial disease characterized by complex I deficiency . Since complex I is critical for ATP production via oxidative phosphorylation, SFXN4 mutations typically result in multisystem disorders affecting tissues with high energy demands .

• Cancer: SFXN4 has been implicated in cancer biology, particularly ovarian cancer . SFXN4 inhibition can sensitize ovarian cancer cells to DNA-damaging drugs and DNA repair inhibitors like cisplatin and PARP inhibitors . This occurs through a dual mechanism: SFXN4 inhibition leads to both oxidative stress from iron accumulation and impaired DNA repair, making cancer cells more vulnerable to DNA-damaging therapies .

How does SFXN4 inhibition sensitize cancer cells to chemotherapy?

SFXN4 inhibition triggers two complementary anti-cancer mechanisms that enhance the effectiveness of DNA-damaging chemotherapeutics:

• Oxidative stress induction: Inhibition of SFXN4 disrupts iron-sulfur (Fe-S) cluster biogenesis, leading to accumulation of excess iron in cancer cells . Through participation in the Fenton reaction and other pathways, this excess iron contributes to oxidative stress, which can damage cancer cells .

• DNA repair inhibition: Many enzymes critical to multiple DNA repair pathways require Fe-S clusters for their function . By inhibiting Fe-S biogenesis, SFXN4 knockdown compromises these DNA repair enzymes, hindering the cell's ability to repair DNA damage .

This dual mechanism makes SFXN4 inhibition particularly effective at sensitizing ovarian cancer cells to cisplatin and PARP inhibitors, even in drug-resistant lines . Furthermore, knockout of SFXN4 has been shown to decrease DNA repair capacity and profoundly inhibit tumor growth in mouse models of ovarian cancer metastasis .

What are optimal expression and purification conditions for recombinant bovine SFXN4?

When expressing and purifying recombinant bovine SFXN4, researchers should consider the following optimization strategies:

• Expression systems:

  • Mammalian expression (HEK293 cells) has been successfully used for SFXN4 expression as demonstrated in complementation studies

  • E. coli systems may require specialized vectors with solubility tags (MBP, GST, SUMO)

• Construct design:

  • C-terminal tags appear to preserve function (FLAG-tagged SFXN4 rescues complex I defects)

  • Consider expressing multiple isoforms, including the shorter isoform 3 which retains all transmembrane domains

• Purification approach:

  • Two-step purification: affinity chromatography followed by size exclusion chromatography

  • Critical use of appropriate detergents (digitonin or Triton X-100 have been successfully used for solubilization in functional studies)

  • Include stabilizing agents (glycerol 10-15%) and reducing agents in buffers

• Functional verification:

  • Ability to rescue complex I assembly and activity in SFXN4 knockout cell lines

  • Formation of appropriate high-molecular-weight complexes as assessed by BN-PAGE

What CRISPR-Cas9 strategies are most effective for studying SFXN4 function?

CRISPR-Cas9 technology provides powerful approaches for studying SFXN4 function. When designing knockout strategies, researchers should consider:

• gRNA design:

  • Target regions common to all isoforms to ensure complete elimination of SFXN4 function

  • The search results mention that SFXN4 has multiple isoforms, including one (isoform 3) that lacks the first ~115 amino acids but still contains all transmembrane domains

• Knockout validation:

  • Verify loss of protein by Western blot

  • Confirm functional defect through complex I activity assays

  • Assess complex I assembly state through BN-PAGE analysis

• Advanced CRISPR applications:

  • Knock-in strategies to introduce specific mutations or tagged versions at the endogenous locus

  • CRISPR interference (CRISPRi) for tunable repression of SFXN4 expression

  • Inducible CRISPR systems to study acute versus chronic effects of SFXN4 loss

• Phenotypic analysis:

  • Blue-Native PAGE to examine complex I assembly intermediates

  • Oxygen consumption measurements to assess respiratory capacity

  • ATP production assays with complex I substrates

Complete SFXN4 knockout has been shown to result in complex I deficiency, reduced oxygen consumption, and impaired ATP production , providing clear functional readouts for successful gene editing.